The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
Between 2012 and 2018, there was a 34.6% increase in the occurrence of mental health diagnoses among children ages 4 to 17, ...